We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Analysis in Real Time Helps Brain Surgeons Remove More Cancerous Tissue

By HospiMedica International staff writers
Posted on 20 Dec 2011
A combination of surgical aspiration and mass spectrometry can determine whether brain tissue is normal or cancerous while surgery is underway, according to a new study. More...


Researchers at Justus Liebig University (JLU; Giessen, Germany), the University of Debrecen (Hungary), and other institutions used a direct combination of a cavitron ultrasonic surgical aspirator (CUSA) and a venturi easy ambient sonic-spray ionization (V-EASI) source to nebulize efficiently suspended tissue material for gas phase ion production. Positive and negative ionization spectra were identified using mass spectrometry, which featured predominantly complex lipid-type constituents in both ion polarity modes. Multiply charged peptide anions were also detected. The spectra of the intact tissue specimens were found to be highly specific to the histological tissue type.

The researchers then examined the influence of instrumental settings, using standard solutions of phospholipids and peptides to test the dynamic range, sensitivity, and suppression effects in detail. Venturi pump geometry and flow parameters were found to be critically important in ionization efficiency. The researchers subsequently developed a real-time tissue identification method for the surgical environment, using principal component analysis (PCA) and linear-discriminant analysis (LDA) based data to identify the margin between cancerous and healthy tissue in half the time previously needed. The study was published in the October 15, 2011, issue of Analytical Chemistry.

“The method has been successfully tested on postmortem and ex vivo human samples including astrocytomas, meningeomas, metastatic brain tumors, and healthy brain tissue,” wrote corresponding author Zoltan Takats, PhD, of the JLU Institute for Inorganic und Analytical Chemistry, and colleagues. “Besides brain surgery, the method has application potential in the field of the surgery of organs including liver, pancreas, or kidney.”

Related Links:

Justus Liebig University
University of Debrecen


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.